{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T10:32:11Z","timestamp":1792492331194,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jbspin.2025.106023","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T16:59:53Z","timestamp":1766422793000},"page":"106023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment sequences of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: A nationwide population-based study in France"],"prefix":"10.1016","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2246-1986","authenticated-orcid":false,"given":"Anna","family":"Molto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8077-8394","authenticated-orcid":false,"given":"Laurent","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2469-920X","authenticated-orcid":false,"given":"M\u00e9lanie","family":"Chartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0021-9005","authenticated-orcid":false,"given":"Arnaud","family":"Panes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8525-9251","authenticated-orcid":false,"given":"Pauline","family":"Lemeille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8845-4274","authenticated-orcid":false,"given":"Bruno","family":"Fautrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2025.106023_bib0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.106023_bib0105","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrrheum.2017.95","article-title":"Managing rheumatic and musculoskeletal diseases - past, present and future","volume":"13","author":"Burmester","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2025.106023_bib0110","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2025.106023_bib0115","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.3390\/jcm11112955","article-title":"Risk of severe infection among rheumatoid arthritis patients on biological DMARDs: a population-based cohort study","volume":"11","author":"Bellan","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jbspin.2025.106023_bib0120","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s10067-019-04449-w","article-title":"Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study","volume":"38","author":"Alten","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2025.106023_bib0125","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1007\/s10067-022-06176-1","article-title":"Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study","volume":"41","author":"Alten","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2025.106023_bib0130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jbspin.2007.06.001","article-title":"The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients","volume":"74","author":"Combe","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2025.106023_bib0135","doi-asserted-by":"crossref","first-page":"A24","DOI":"10.1016\/j.rhum.2021.10.034","article-title":"Prise en charge suboptimale de la polyarthrite rhumato\u00efde en France \u00e0 partir des donn\u00e9es de la base nationale de l\u2019Assurance Maladie","volume":"88","author":"Gaujoux-Viala","year":"2021","journal-title":"Rev Rhum"},{"key":"10.1016\/j.jbspin.2025.106023_bib0140","article-title":"Prevalence, mortality, and treatment of patients with rheumatoid arthritis: a cohort study of the French Nation Health Data System, 2010-2019","author":"Vegas","year":"2023","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2025.106023_bib0145","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: From the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.jbspin.2025.106023_bib0150","first-page":"1","article-title":"France: health system review","volume":"17","author":"Chevreul","year":"2015","journal-title":"Health Syst Transit"},{"key":"10.1016\/j.jbspin.2025.106023_bib0155","series-title":"M\u00e9thodologie m\u00e9dicale de la cartographie des pathologies et des d\u00e9penses version G8 (ann\u00e9es 2015 \u00e0 2019, Tous R\u00e9gimes)","year":"2021"},{"key":"10.1016\/j.jbspin.2025.106023_bib0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MLR.0000000000000471","article-title":"The best use of the Charlson Comorbidity Index with electronic health care database to predict mortality","volume":"54","author":"Bannay","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.jbspin.2025.106023_bib0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jbspin.2018.10.002","article-title":"Update of French society for rheumatology recommendations for managing rheumatoid arthritis","volume":"86","author":"Daien","year":"2019","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2025.106023_bib0175","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1002\/art.30524","article-title":"Remission of rheumatoid arthritis in clinical practice: application of the American College of Rheumatology\/European League Against Rheumatism 2011 remission criteria","volume":"63","author":"Shahouri","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2025.106023_bib0180","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.rhum.2020.07.011","article-title":"Facteurs pr\u00e9dictifs du maintien sous traitement par inhibiteurs du facteur de n\u00e9crose tumorale dans la polyarthrite rhumato\u00efde\u00a0: \u00e9tude observationnelle sur 8052 patients","author":"Fautrel","year":"2020","journal-title":"Rev Rhum"},{"key":"10.1016\/j.jbspin.2025.106023_bib0185","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3899\/jrheum.151212","article-title":"Adherence and persistence with methotrexate in rheumatoid arthritis: a systematic review","volume":"43","author":"Curtis","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2025.106023_bib0190","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s40744-021-00311-1","article-title":"Elicitation of rheumatologist preferences for the treatment of patients with rheumatoid arthritis after the failure of a first conventional synthetic disease-modifying anti-rheumatic agent","volume":"8","author":"Senbel","year":"2021","journal-title":"Rheumatol Ther"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X2500185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X2500185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T23:57:51Z","timestamp":1778198271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X2500185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1297319X2500185X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2025.106023","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment sequences of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: A nationwide population-based study in France","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2025.106023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie.","name":"copyright","label":"Copyright"}],"article-number":"106023"}}